Adage Capital Partners
ASMB icon

Adage Capital Partners’s Assembly Biosciences ASMB Stock Holding History

Adage Capital Partners’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-161,000
Closed -$4.47M – 1008
2026
Q1 		$4.47M Hold
161,000
– – 0.01% 781
2025
Q4 		$5.48M Buy
+161,000
New +$5.19M 0.01% 752
2020
Q1 		– Sell
-6,458
Closed -$1.59M – 730
2019
Q4 		$1.59M Buy
+6,458
New +$1.19M ﹤0.01% 665
2019
Q2 		– Sell
-6,250
Closed -$1.48M – 703
2019
Q1 		$1.48M Hold
6,250
– – ﹤0.01% 653
2018
Q4 		$1.7M Hold
6,250
– – ﹤0.01% 666
2018
Q3 		$2.79M Sell
6,250
-10,417
-63% -$4.88M 0.01% 665
2018
Q2 		$7.84M Buy
16,667
+2,084
+14% +$1.1M 0.02% 602
2018
Q1 		$8.6M Hold
14,583
– – 0.02% 581
2017
Q4 		$7.92M Buy
+14,583
New +$6.6M 0.02% 594

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Adage Capital Partners's ASMB Position: Q2 2026 in Review

Adage Capital Partners sold out of Assembly Biosciences (ASMB) in Q2 2026, closing a stake of 161,000 shares — an estimated $4.47M sold.

Adage Capital Partners first reported a position in ASMB in Q4 2017 and held it in 9 quarters. The position peaked at $8.6M in Q1 2018. 93 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

  • Adage Capital Partners reported no remaining Assembly Biosciences position as of Q2 2026 after selling out during the quarter.
  • Adage Capital Partners sold 161,000 Assembly Biosciences shares in Q2 2026, an estimated $4.47M.
  • Adage Capital Partners first reported a position in Assembly Biosciences in Q4 2017 and held it in 9 quarters.
  • Adage Capital Partners's Assembly Biosciences position peaked at $8.6M in Q1 2018.
  • 93 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.